Cited 0 times in Scipus Cited Count

Toluene diisocyanate (TDI) regulates haem oxygenase-1/ferritin expression: implications for toluene diisocyanate-induced asthma.

DC Field Value Language
dc.contributor.authorKim, SH-
dc.contributor.authorChoi, GS-
dc.contributor.authorYe, YM-
dc.contributor.authorJou, I-
dc.contributor.authorPark, HS-
dc.contributor.authorPark, SM-
dc.date.accessioned2011-04-28T04:43:38Z-
dc.date.available2011-04-28T04:43:38Z-
dc.date.issued2010-
dc.identifier.issn0009-9104-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/2490-
dc.description.abstractDiisocyanate is a leading cause of occupational asthma (OA). Diisocyanate-induced OA is an inflammatory disease of the airways that is associated with airway remodelling. Although the pathogenic mechanisms are unclear, oxidative stress may be related to the pathogenesis of diisocyanate-induced OA. In our previous report, we observed that the expression of ferritin light chain (FTL) was decreased in both of bronchoalveolar lavage fluid and serum of patients with diphenyl-methane diisocyanate (MDI)-induced OA compared to those of asymptomatic exposed controls and unexposed healthy controls. In this study of toluene diisocyanate (TDI)-OA, we found identical findings with increased transferrin and decreased ferritin levels in the serum of patients with TDI-OA. To elucidate whether diisocyanate suppresses FTL synthesis directly, we tested the effect of TDI on the FTL synthesis in A549 cells, a human airway epithelial cell line. We found that haem oxygenase-1 as well as FTL was suppressed by treatment with TDI in dose- and time-dependent manners. We also found that the synthesis of other anti-oxidant proteins such as thioredoxin-1, glutathione peroxidase, peroxiredoxin 1 and catalase were suppressed by TDI. Furthermore, TDI suppressed nuclear translocation of Nrf2 through suppressing the phosphorylation of mitogen-activated protein kinases (MAPKs); extracellular-regulated kinase 1/2 (ERK1/2); p38; and c-Jun N-terminal kinase (JNK). Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists, 15-deoxy-Delta(12,14)-PGJ2 and rosiglitazone rescued the effect of TDI on HO-1/FTL expression. Collectively, our findings suggest that TDI suppressed HO-1/FTL expression through the MAPK-Nrf2 signalling pathway, which may be involved in the pathogenesis of TDI-induced OA. Therefore, elucidating these observations further should help to develop the therapeutic strategies of diisocyanate-induced OA.-
dc.language.isoen-
dc.subject.MESHActive Transport, Cell Nucleus-
dc.subject.MESHAdult-
dc.subject.MESHApoferritins-
dc.subject.MESHAsthma-
dc.subject.MESHCatalase-
dc.subject.MESHCell Line-
dc.subject.MESHCell Nucleus-
dc.subject.MESHChemical Industry-
dc.subject.MESHFemale-
dc.subject.MESHGene Expression Regulation-
dc.subject.MESHGlutathione Peroxidase-
dc.subject.MESHHeme Oxygenase-1-
dc.subject.MESHHumans-
dc.subject.MESHHypoglycemic Agents-
dc.subject.MESHImmunologic Factors-
dc.subject.MESHMAP Kinase Signaling System-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHMitogen-Activated Protein Kinase Kinases-
dc.subject.MESHNF-E2-Related Factor 2-
dc.subject.MESHOccupational Exposure-
dc.subject.MESHPPAR gamma-
dc.subject.MESHPeroxiredoxins-
dc.subject.MESHProstaglandin D2-
dc.subject.MESHRespiratory Mucosa-
dc.subject.MESHThiazolidinediones-
dc.subject.MESHThioredoxins-
dc.subject.MESHToluene 2,4-Diisocyanate-
dc.subject.MESHTransferrin-
dc.titleToluene diisocyanate (TDI) regulates haem oxygenase-1/ferritin expression: implications for toluene diisocyanate-induced asthma.-
dc.typeArticle-
dc.identifier.pmid20345975-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883121/-
dc.contributor.affiliatedAuthor김, 승현-
dc.contributor.affiliatedAuthor최, 길순-
dc.contributor.affiliatedAuthor예, 영민-
dc.contributor.affiliatedAuthor주, 일로-
dc.contributor.affiliatedAuthor박, 해심-
dc.contributor.affiliatedAuthor박, 상면-
dc.type.localJournal Papers-
dc.identifier.doi10.1111/j.1365-2249.2010.04118.x-
dc.citation.titleClinical and experimental immunology-
dc.citation.volume160-
dc.citation.number3-
dc.citation.date2010-
dc.citation.startPage489-
dc.citation.endPage497-
dc.identifier.bibliographicCitationClinical and experimental immunology, 160(3). : 489-497, 2010-
dc.identifier.eissn1365-2249-
dc.relation.journalidJ000099104-
Appears in Collections:
Journal Papers > Hospital > Clinical Trial Center
Journal Papers > School of Medicine / Graduate School of Medicine > Allergy
Journal Papers > School of Medicine / Graduate School of Medicine > Pharmacology
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse